Document Detail


Combined hyperlipidemia in a single subject with tetraplegia: ineffective risk reduction after atorvastatin monotherapy.
MedLine Citation:
PMID:  15648805     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/OBJECTIVE: Effects of atorvastatin (Lipitor) drug monotherapy (10 mg daily) on fasting blood lipid profiles and cardiovascular disease (CVD) risks were examined for a single subject with C5-C6 tetraplegia. Routine fasting lipid profiles were analyzed by standard biochemistry techniques for total cholesterol (TC), triglycerides (TG), low-density lipoprotein-cholesterol (LDL-C), and high-density lipoprotein-cholesterol (HDL-C). Lipid profiles were analyzed on 3 occasions before drug therapy was initiated and 3 months after therapy commenced. The TC:HDL and LDL:HDL ratios were computed for all sampling times and used to assess pretreatment and post-treatment CVD risk. RESULTS: Fasting TC, TG, and LDL-C were all significantly reduced by therapy. The pretreatment HDL-C of 35 mg/dL was lowered to 21 mg/dL. As a result, the TC:HDL risk ratio was only marginally reduced from 6.6 to 6.4, whereas the LDL:HDL risk ratio remained unchanged by treatment. CONCLUSIONS: In this man with tetraplegia, atorvastatin drug monotherapy rapidly lowered TC, TG, LDL-C, and HDL-C. However, the TC:HDL ratio, considered the best predictor of CVD risk, was unchanged.
Authors:
Mark S Nash; Brad M Johnson; Patrick L Jacobs
Related Documents :
17536125 - Pistachio nut consumption and serum lipid levels.
2837895 - Effects of solid and liquid guar gum on plasma cholesterol and triglyceride concentrati...
183495 - Pseudohomozygous and pseudoheterozygous type ii hyperlipoproteinemia.
12090905 - High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
17935245 - Effects of two whole blood systems (dali and liposorber d) for ldl apheresis on lipids ...
15032435 - Influence of early postmortem protein oxidation on beef quality.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The journal of spinal cord medicine     Volume:  27     ISSN:  1079-0268     ISO Abbreviation:  J Spinal Cord Med     Publication Date:  2004  
Date Detail:
Created Date:  2005-01-14     Completed Date:  2005-03-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9504452     Medline TA:  J Spinal Cord Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  484-7     Citation Subset:  IM    
Affiliation:
Department of Neurological Surgery, University of Miami School of Medicine, Miami, Florida 33136, USA. msnash@miami.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticholesteremic Agents / therapeutic use*
Cardiovascular Diseases / blood,  prevention & control*
Cervical Vertebrae / injuries
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Follow-Up Studies
Heptanoic Acids / therapeutic use*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hyperlipidemia, Familial Combined / blood,  diagnosis,  drug therapy*
Male
Odds Ratio
Pyrroles / therapeutic use*
Spinal Cord Injuries / blood*
Treatment Failure
Triglycerides / blood
Wounds, Gunshot / blood*
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrroles; 0/Triglycerides; 110862-48-1/atorvastatin; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Emergency thoracic diskectomy for the acute onset of paraplegia: report of two cases.
Next Document:  Comparison of the effects of cyclic stretching and compression on endothelial cell morphological res...